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Abstract Increased levels of glutathione (GSH) occur in the 
epithelial lining fluid (ELF) of chronic cigarette smokers. 
Therefore we investigated the effect of cigarette smoke 
condensate solution (CSC) on GSH synthesis and the regulation 
of T-glutamylcysteine synthetase (~CS)  in human type II 
alveolar epithelial cells (A549). CSC exposure increased GSH 
levels, TGCS activity and ~CS heavy subunit (HS) mRNA, as 
well as increasing DNA binding of the activator protein-1 (AP-1) 
and the human antioxidant response lement (hARE). Transfec- 
tion of deletion constructs of the ~GCS-HS promoter in a 
chloramphenicol acetyl transferase (CAT) reporter system 
revealed that an hARE, present within promoter, is not required 
tot the CSC mediated induction. We conclude that CSC 
induction of ~GCS-HS expression is associated with AP-1/AP- 
I-like responsive lements. 
~(,ey words: Glutathione; 7-Glutamylcysteine synthetase; 
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!. Introduction 
The capacity of mammalian cells to maintain homeostasis 
:,f cellular functions during oxidative stress depends on the 
~apid induction of protective antioxidant enzymes [1 3]. Re- 
iuced glutathione (GSH), a ubiquitous cellular non-protein 
• ulphydryl, functions to maintain cellular redox balance and 
J~ also involved in the detoxification of xenobiotics, electro- 
i~hiles, organic peroxides and heavy metals, either through 
~firect hiol conjugation or in enzyme-catalysed r actions [4]. 
We and others have demonstrated increased levels of GSH in 
,~ssociation with an increased oxidant burden in the epithelial 
Lining fluid (ELF) of healthy chronic smokers [5,6]. The mech- 
,nism of this increase in GSH is currently unknown. 
Glutathione is synthesised from its constituent amino acids 
~n two sequential, ATP-dependent enzymatic reactions cata- 
ysed by y-glutamylcysteine synthetase (~3CS) and GSH 
,ynthase [7]. ~GCS is the rate-limiting step in de novo GSH 
ynthesis and is inhibited by a feedback mechanism. In cells, 
he ~GCS, holoenzyme exists as a dimer composed of heavy 
~,/GCS-HS; 73 kDa) and light (~CS-LS;  28 kDa) subunits 
8]. The heavy subunit possesses all of the catalytic activity [9]. 
Cigarette smoke contains 1014-1016 free radicals/puff and a 
Lost of highly electrophilic hemical compounds [10]. Re- 
ently, we have shown that cigarette smoke condensate solu- 
tion (CSC) rapidly depletes intracellular GSH, by a mechan- 
ism involving the formation of GSH-conjugates in the human 
~dveolar type II epithelial cell line, A549 [11]. However, this 
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effect was reversed after the cells were cultured in fresh me- 
dium, with a significant increase in GSH concentrations 12h 
after exposure. We hypothesised that GSH synthesis may be 
induced in alveolar epithelial cells as an adaptive response to 
CSC exposure by upregulation of ~SCS-HS gene expression. 
These findings may be relevant o the enhanced GSH levels 
which are present in the ELF of chronic smokers [5,6]. 
Mulcahy and Jipp [12] and Yao et al. [13] recently reported 
that the promoter (5'-flanking) region of the human 7GCS-HS 
gene contained a consensus fos/jun heterodimeric complex-ac- 
tivator protein (AP-1) sequence, AP-l-like binding sites; an 
human-antioxidant response element (hARE), and several 
SP-1 and AP-2 binding sites. However there is no information 
so far available about the characteristics of the ~GCS-HS 
promoter egion and the regulation of GSH synthesis. 
In this study we hypothesised that CSC induced ~GCS-HS 
gene expression in airspace pithelial cells, which may be re- 
lated to the increase in the DNA binding of transcription 
factors to the promoter egions of 7GCS-HS gene. We there- 
fore investigated the effect of CSC on the regulation of'~GCS- 
HS mRNA and the DNA binding activities of AP-1 and 
hARE, transcription factors in alveolar epithelial cells. We 
also for the first time, partially characterised the 5'-region 
of the 7GCS-HS gene by creating deletion constructs and 
analysed the involvements of various transcription factors 
sites in the regulation of ~<3CS-HS promoter. 
2. Materials and methods 
Unless otherwise stated, all of the biochemical reagents used in this 
study were purchased from the Sigma Chemical Co., Poole, UK; cell 
culture media nd molecular biology reagents from Gibco-BRL (Pais- 
ley, UK): and the gel shift assay kit from Promega, Southampton, 
UK. 
2.1. A549 epithelial cells 
The type II alveolar epithelial cell line, A549 (ECACC No. 
86012804), which was mycoplasma free, was maintained incontinuous 
culture at 37°C, 5% CO2 in Dulbecco's modified minimum essential 
medium (DMEM, Gibco) containing penicillin/streptomycin mixture, 
L-glutamine, sodium bicarbonate, and 10% fetal bovine serum (FBS) 
(Gibco). 
2.2. Preparation of CSC 
CSC (100%) was produced from standard cigarettes ach containing 
23 mg of tar and 2.2 mg of nicotine (University of Kentucky UK2R1). 
CSC was produced by blowing smoke, generated by a smoking ma- 
chine using a vacuum syringe system, over 3 ml of phosphate buffered 
saline (PBS) in a siliconised glass tonometer (Vitalograph, Bucking- 
ham, UK). The smoke-generating machine delivers a 37 ml puff of 
whole cigarette smoke, including particulates, every minute to the 
tonometer which was rotated gently [14]. The solution was made up 
fresh on the morning of each experiment and CSC (100%) was filtered 
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using 0.22 ~tm filter (Millipore S.A., Molsheim, France) to remove 
large particles and bacteria. 
2.3. A549 epithelial cell exposure to CSC 
Confluent monolayers of A549 cells were rinsed twice with DMEM 
and exposed to CSC (1, 5, 10% dilutions with PBS) for 4 h in 5 ml of 
DMEM with 10% FBS at 37°C, 5% CO2. After incubation, the mono- 
layers were washed with fresh medium and incubated for a further 12 
or 24 h. The monolayers were then washed twice with cold sterile PBS 
(Ca 2+ and Mg 2+ free) (pH 7.4), trypsinised and used for the GSH, 
~3CS enzyme and mRNA assays. For gel shift assays, the cells were 
scraped into ice cold PBS and used for the preparation of nuclear 
extracts. In some experiments, monolayers were washed with PBS and 
exposed to 10% CSC with fresh medium with 10% FBS at 37°C in 5% 
CO2, for an additional 12 h. The cells were then harvested and used 
for the GSH, mRNA and electrophoresis mobility shift assays 
(EMSA). 
2.4. GSH, GSSG and ?GCS activity assays 
Acid extracts of A549 cells, were spun and the supernatant imme- 
diately used in the soluble GSH assay by the 5,5'-dithiobis-(2-nitro- 
benzoic acid) DTNB-GSSG reductase r cycling method escribed by 
Tietze [15]. For the GSSG assay, acid extract was treated with 2- 
vinylpyridine and triethanolamine as previously described [16], and 
the treated supernatant was used in the assay [15]. 7GCS activity 
was measured by the method escribed by Seelig and Meister [17]. 
2.5. Preparation of nuclear extracts and EMSA 
Nuclear extracts were prepared by the method of Staal et al. [18]. 
The oligonucleotides u ed were: hARE: 5'-ATC CAG TCA CAG 
TGA CTC AG-3', 3'-TAG GTC AGT GTC ACT GAG TC-5', 
synthesised by Oswel DNA Services, Edinburgh, UK; and AP-I: 
5'-CGC TTG ATG AGT CAG CCG GAA-3', 3'-CGC AAC TAC 
TCA GTC GGC CTT-5', obtained from Promega. The hARE and 
AP-1 oligonucleotides were end-labelled with [7-32P]ATP using T4 
polynucleotide kinase and poly(dI-dC), poly(dI-dC) according to the 
manufacturers instructions (Promega). Binding reactions were carried 
out as per the manufacturers in tructions using 4 ~tg of nuclear-extract 
protein for AP-1 and 15-20 p.g nuclear-extract protein for hARE 
EMSA assays. The protein-DNA complexes were resolved on non- 
denaturing polyacrylamide g ls. The gels were then vacuum dried and 
aut.oradiographed with an intensifying screen overnight at -80oc. 
2.6. Isolation of RNA and reverse transcription 
RNA was isolated from A549 cells by the acid-guanidine method 
described by Chomczynski and Sacchi [19]. Total RNA was reverse 
transcribed using superscript II according to the manufacturer's in-
structions (Gibco-BRL). The resultant cDNA was stored at -20°C, 
until required. 
2. 7. Primers and polymerase chain reaction (PCR) 
To quantitate "~,GCS mRNA expression the reverse transcriptase- 
PCR assay was used. Oligonucleotide primers were chosen using the 
published sequence of ~3CS-HS cDNA [20], and !3-actin (Stratagene, 
Cambridge, UK). The primers for 7GCS-HS were synthesised by Os- 
wel DNA Services, University of Edinburgh, UK, with the se- 
quences:The r verse transcribed mRNA mixture (5 ~g) was added 
directly to the PCR mixture which consisted of buffer (10 mM Tris- 
HCI, pH 8.4, 50 mM KCI, 2.5 mM MgC12), 200 ~tM dNTPs and 20 
pmoles of each primer, 1 U of Taq DNA polymerase in a final volume 
of 55 ~tl. Thirty-five cycles were repeated for the amplification of ~- 
actin and 7GCS-HS. Conditions for the thermal cycles were: ~actin: 
denatured at 94°C for 60 s, annealing at 60°C for 60 s, extension at 
72°C for 60 s and final extension at 72°C for 10 s; ~/GCS: denatured 
at 94°C for 30 s, annealing at 56°C for 30 s, extension at 72°C for 120 
s and final extension 72°C for 5 min. 25 I11 of the amplified PCR 
products was applied to a 2% agarose gel containing ethidium bro- 
mide and electrophoresed in 0.5×Tris-borate-EDTA buffer. Bands 
were visualised by uv transilluminator and photograph negatives 
were scanned using a LKB-ultrascan XL enhanced laser densitometer. 
The relative levels of the ~3CS-HS mRNA were estimated by com- 
parison with the intensity of the [3-actin bands and expressed as a 
percentage. The positive control for ~<3CS-HS was the pKS-hGCS 
plasmid (American type culture collection, Rockville, MD, Cat no. 
79023). 50 fg was used for each reaction to check the specificity of the 
PCR. The ~3CS-HS PCR product (531 bp) was checked by digestion 
with the restriction endonuclease BspHI (New England Biolabs) which 
produced in two fragments 314 bp and 217 bp in size, which is in 
agreement with ~GCS-HS cDNA sequence [20]. Serial dilutions (1:10, 
1:100) of first strand cDNAs of y-GCS-HS and I~-actin were used to 
check the specificity and sensitivity of RT-PCR assay. 
2.8. Actinomycin D and cycloheximide treatments 
Confluent cells were treated with 10% CSC together with 0.05 ~tg/ml 
actinomycin D or 0.5 ~g/ml cycloheximide in culture medium for 4 h. 
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Fig. 1. Transient expression analysis of the human "?GCS-HS gene. The line diagram at the top is a restriction map of the promoter region 
cloned in pCRII vector. Dotted line on the left indicates an additional 50 bp from multiple cloning sites of pCRII vector. Transcriptional start 
site is indicated by the bent arrow. The structure of the "t(JCS-CAT plasmids are showed on the left. Deletion mutants were ligated upstream 
of the CAT gene in pCAT Basic vector (pCB), transfected into A549 cells and exposed to CSC. After 24 h incubation the cells were harvested 
and assayed for CAT activity. The activities of the different constructs are expressed as means_+ S.E.M. of triplicate transfection experiments, 
each performed in duplicates with the activity of pCBGCS set at 100%. ***P< 0.001 compared to pCBGCS. 
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t:ig. 2. Effect of cigarette smoke condensate solution (CSC) on ~GCS-HS mRNA expression in A549 cells. Total RNA was isolated from con- 
l rol cells and cells exposed to different concentrations of CSC for (A) 24 h. RNA was reversed transcribed and used for PCR analysis of 
GCS-HS mRNA. (B) The gel was scanned on a LKB ultrascan enhanced laser densitometer and the numeric estimates of yGCS-HS mRNA 
zvels compared with the subsequent 13-actin bands from the same sample. The relative percentages of ~GCS-HS mRNA to 13-actin were ex- 
!,ressed as the mean _+ S.E.M. of six experiments each performed in duplicate. ***P < 0.001 compared to control (C) values. 
'he cells were then washed as before and re-incubated with actino- 
,lycin D or cycloheximide alone, in fresh culture medium for an 
dditional 12 h. 
(-817 to +45 bp) (pCBGCSz~K) containing AP-1 and AP-l-like 
sites (Fig. 1). Both the fragments were subcloned into pCAT Basic 
vector. 
.9. Promoter deletion constructs 
The ~3CS-HS promoter was isolated by PCR from human genomic 
I)NA using the upstream oligonucleotide 5'- (+82) GGCGACATC- 
~;AATATGAAGGCTGTG-3' and downstream oligonucleotides 5'- 
-1050) TTCCTACTTGTGACCAAAACCTGCG-Y. The resulting 
~,romoter f agment (-1050 to +82 bp) was cloned into pCRII cloning 
, ector (Invitrogen) and a HindllI  and SphI fragment (1138 bp) con- 
'.fining the promoter was isolated and subcloned into polylinker of the 
;,romoterless plasmid pCAT Basic vector (Promega) which was named 
s pCBGCS. Deletion fragments of the 7GCS-HS promoter were 
cenerated using KpnI restriction site present within the ~GCS-HS 
;,romoter which resulted in the short fragment containing hARE 
-1050 to -818 bp) (pCBGCSA) and remaining large fragment 
2.10. Transient ransfection and CAT assay 
A549 cells (,~ 0.8 x 106) per well were seeded into 6-well tissue cul- 
ture plates and cultured at 37°C until the cell density reached ~ 60- 
70% confluence. Plasmid DNA transfections were performed using 
lipofectAMINE reagent (Gibco), according to the manufacturer's in-
structions. After CSC treatments, the cell extracts were prepared and 
assayed for protein content using BCA reagent (Pierce, Rockford, IL, 
USA). Chloramphenicol acetyl transferase (CAT) activity was quan- 
titated by the CAT enzyme-linked immunosorbent assay (ELISA). 
13-galactosidase expression plasmid (PSVgal, Promega) was cotrans- 
fected as an internal control to normalise the transfection efficiency. 
In all transfection experiments, pCAT-Basic, pCAT-Control were 
used as negative and positive controls, respectively. 
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I:ig. 3. Transcriptional regulation of ~GCS-HS mRNA in A549 cells. (A) Effects of actinomycin D and cycloheximide on CSC-induced ~3CS- 
IlS mRNA expression. (B) Densitometric quantitation of 7GCS-HS mRNA compared to [~-actin mRNA. The data expressed as the mean 
-~_ S.E.M. of triplicate xperiments each performed in duplicate. ***P < 0.001 compared to control (C) values. 
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Fig. 4. Effect of CSC solution exposure on the induction of AP-1 and hARE binding activities in A549 cells. Nuclear extracts were prepared 
and analysed by the electrophoretic mobility shift assay. (A) AP-1, and (B) hARE binding activities in nuclear extracts from A549 cells un- 
treated or exposed to CSC performed in quadriplicate. Nuclear extracts from HeLa cells were used as a positive control. 
2.11. Statistical analysis 
Results were expressed as mean (S.E.M.). Differences between val- 
ues were compared by Duncan's multiple range test. Statistical ana- 
lyses were performed using SPSS/PC + 4.0 package. 
3. Results and discussion 
We have previously shown that exposure of A549 cells to 
CSC produced a dose- and time-dependent depletion of intra- 
cellular GSH [11]. This was not due to oxidation of GSH or 
protein thiolation, but was associated with a decrease in ~/GCS 
activity and increased GSH-conjugate formation [11]. In the 
present study we show that after this initial depletion of GSH 
by CSC, prolonged re-culture (i.e. 24 h) results in an increase 
in GSH levels (control 15.6_+0.4, 10%; CSC 21.7_+1.4 
nmoles/106 cells, P<0.05, n=6) with no change in GSSG 
concentrations (control 1.0_+0.3, 10%; CSC 1.2+0.4 
nmoles/1016 cells, P= NS, n = 6) and a concomitant increase 
in "¢GCS activity (control 0.24-+0.04, 10%; CSC 0.36+0.06 
U/mg protein, P < 0.01, n = 6). We show that these events are 
associated with a dose-dependent i crease in the relative level 
of "~GCS-HS mRNA (Fig. 2A,B) and that this induction oc- 
curs at the transcriptional level, since co-incubation with acti- 
nomyein D but not cycloheximide eliminated the increase of 
~/GCS-HS mRNA (Fig. 3A,B). GSH levels have been shown 
to be twofold higher in the ELF [5,6] and erythrocytes [21] of 
chronic cigarette smokers so induction of ~(3CS-HS mRNA 
by CSC in epithelial cells is a possible mechanism for this 
elevation of GSH since intracellular GSH is exported from 
alveolar epithelial cells [22,23]. CSC also induces DNA-bind- 
ing of the redox sensitive transcription factors AP-1 (fos/jun 
heterodimeric complex) and hARE in A549 cells (Fig. 4A,B). 
Response elements for these transcription factors, together 
with others such as AP-2 and SP-1, are present in the prox- 
imal 5'-promoter region of ~GCS-HS [12,13], therefore our 
observation of induction of ~/GCS-HS mRNA may be related 
to the increased AP-1 and hARE binding activities. 
~K3CS-HS has been shown to be induced by various redox- 
regulating agents [24-27] but the precise stimulus for the in- 
duction of ~(3CS-HS mRNA following CSC exposure is not 
clear. Aqueous solution of CSC contains highly electrophilic 
compounds capable of generating H202 [28] and heavy met- 
als, such as cadmium [10], which may modulate the AP-1 
transcription factor [29,30]. In support of this, induction of 
the mRNAs of the AP-1 components (i.e. c-fos and c-jun) has 
recently been described in Swiss 3T3 cells exposed to CSC [31] 
and in tracheobronchial epithelial cells [32]. Induction of AP-1 
may explain the upregulation of ~3CS-HS mRNA in alveolar 
epithelial cells. This is further substantiated by~[3CS-HS pro- 
moter deletion studies. The full proximal promoter (-1050 to 
+82 bp) linked to the CAT reporter system (pCBGCS) pro- 
duced increased CAT activity on exposure to CSC. However, 
deletion of a 232 bp fragment containing the hARE respon- 
sive element, did not affect this induction (Fig. 1). This sug- 
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gests that this hARE is not involved in the regulation of 
7GCS-HS activity in response to CSC. Rather, downstream 
sequences, i.e. -817  to +1 bp containing AP-1/AP-I-like re- 
sponsive elements are required. This is in good agreement 
with an earlier indirect observation that c-jun/c-jun homodi- 
mers (AP-1) regulate ~3CS-HS gene expression induced by 
isplatin [13] and cadmium [33]. However, there may be an- 
ther hARE element present further upstream in the ~GCS- 
i 1S gene which could affect enzyme induction. Further studies 
re in progress to characterise and identify other response 
, lements as well as the specific region of "/GCS-HS promoter 
Jhich regulate basal ~GCS-HS gene expression. 
In summary, we have shown a dose-dependent elevation in 
teady state level of mRNA for the ,/GCS-HS in A549 cells in 
esponse to CSC. Analysis of "~3CS-HS promoter revealed 
avolvement of AP-1/AP-I-like responsive lements and not 
,ARE in the regulation of ~GCS activity. These observations 
,rovide a mechanism for the redox regulation of ~GCS-HS 
,aRNA at the transcription level, and may explain the in- 
reased GSH levels found in epithelial lining fluid of chronic 
igarette smokers. 
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